Tapewire

Nasdaq · USD

GH

Guardant Health, Inc.

Export transactions ↓
Tapewire entity
3238
SEC CIK
0001576280
Parsed reports
867

Last 12 months

Inside the activity.

1 purchase rows · 142 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 2025048
Jan 202606
Feb 202600
Mar 202606
Apr 202602
May 2026024
Jun 2026126
Jul 202601
Aug 2026017
Sep 202608
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 06, 2020 Filed Jul 7, 2020 00:12 UTC
Talasaz AmirAliDirector · Chairman, President and COO
Exercise / conversionCOMMON STOCK 20,108 $4.18 $84,051.44
Disclosure

SEC source: 0001628280-20-010229 · wf-form4_159408074472014.xml · nonDerivative · entry 5

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,709,640

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 00:12 UTC
Talasaz AmirAliDirector · Chairman, President and COO
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative 54,892 $0.00 Strike: $4.18 $0.00
Disclosure

SEC source: 0001628280-20-010229 · wf-form4_159408074472014.xml · derivative · entry 9

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 710,613

Underlying: COMMON STOCK · 54,892 shares

Expires 2022-07-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 00:12 UTC
Talasaz AmirAliDirector · Chairman, President and COO
SaleCOMMON STOCK 1,060 $84.81 $89,896.27
Disclosure

SEC source: 0001628280-20-010229 · wf-form4_159408074472014.xml · nonDerivative · entry 4

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,689,532

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F4 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $84.715 to $84.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 00:12 UTC
Talasaz AmirAliDirector · Chairman, President and COO
SaleCOMMON STOCK 44,299 $83.93 $3,718,054.94
Disclosure

SEC source: 0001628280-20-010229 · wf-form4_159408074472014.xml · nonDerivative · entry 3

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,690,592

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $83.68 to $84.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 00:12 UTC
Talasaz AmirAliDirector · Chairman, President and COO
SaleCOMMON STOCK 9,533 $83.48 $795,842.49
Disclosure

SEC source: 0001628280-20-010229 · wf-form4_159408074472014.xml · nonDerivative · entry 2

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,734,891

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $82.68 to $83.675, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 00:12 UTC
Talasaz AmirAliDirector · Chairman, President and COO
Exercise / conversionCOMMON STOCK 54,892 $4.18 $229,448.56
Disclosure

SEC source: 0001628280-20-010229 · wf-form4_159408074472014.xml · nonDerivative · entry 1

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,744,424

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 25, 2020 Filed Jun 29, 2020 21:59 UTC
CLARK IAN TDirector
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative 538 $0.00 Strike: $4.18 $0.00
Disclosure

SEC source: 0001628280-20-010027 · wf-form4_159346793716690.xml · derivative · entry 3

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,608

Underlying: COMMON STOCK · 538 shares

Expires 2027-11-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on October 25, 2017.

Read SEC document
June 25, 2020 Filed Jun 29, 2020 21:59 UTC
CLARK IAN TDirector
SaleCOMMON STOCK 538 $81.27 $43,723.26
Disclosure

SEC source: 0001628280-20-010027 · wf-form4_159346793716690.xml · nonDerivative · entry 2

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,643

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
June 25, 2020 Filed Jun 29, 2020 21:59 UTC
CLARK IAN TDirector
Exercise / conversionCOMMON STOCK 538 $4.18 $2,248.84
Disclosure

SEC source: 0001628280-20-010027 · wf-form4_159346793716690.xml · nonDerivative · entry 1

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,181

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 17:56 UTC GrantSTOCK OPTION (RIGHT TO BUY) · Derivative 4,840 $0.00 Strike: $77.09 $0.00
Disclosure

SEC source: 0001628280-20-009564 · wf-form4_159234457407405.xml · derivative · entry 2

MERESMAN STANLEY J · CIK 0001283102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,840

Underlying: COMMON STOCK · 4,840 shares

Expires 2030-06-11

F1 · derivative.exercise_date: The stock option vests in full on the earlier to occur of (i) June 12, 2021 and (ii) the date of the next annual meeting of the Issuer's stockholders.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 17:56 UTC GrantCOMMON STOCK 2,757 $0.00 $0.00
Disclosure

SEC source: 0001628280-20-009564 · wf-form4_159234457407405.xml · nonDerivative · entry 1

MERESMAN STANLEY J · CIK 0001283102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,059

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:56 UTC
CLARK IAN TDirector
GrantSTOCK OPTION (RIGHT TO BUY) · Derivative 4,840 $0.00 Strike: $77.09 $0.00
Disclosure

SEC source: 0001628280-20-009565 · wf-form4_159234459513966.xml · derivative · entry 2

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,840

Underlying: COMMON STOCK · 4,840 shares

Expires 2030-06-11

F1 · derivative.exercise_date: The stock option vests in full on the earlier to occur of (i) June 12, 2021 and (ii) the date of the next annual meeting of the Issuer's stockholders.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:56 UTC
CLARK IAN TDirector
GrantCOMMON STOCK 3,341 $0.00 $0.00
Disclosure

SEC source: 0001628280-20-009565 · wf-form4_159234459513966.xml · nonDerivative · entry 1

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,643

Read SEC document
June 12, 2020 Filed Jun 16, 2020 17:56 UTC
Kaul SamirDirector
GrantSTOCK OPTION (RIGHT TO BUY) · Derivative 4,840 $0.00 Strike: $77.09 $0.00
Disclosure

SEC source: 0001628280-20-009563 · wf-form4_159234455112778.xml · derivative · entry 3

Kaul Samir · CIK 0001501915 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,840

Underlying: COMMON STOCK · 4,840 shares

Expires 2030-06-11

F2 · derivative.exercise_date: The stock option vests in full on the earlier to occur of (i) June 12, 2021 and (ii) the date of the next annual meeting of the Issuer's stockholders.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 17:56 UTC
Kaul SamirDirector
GrantCOMMON STOCK 2,757 $0.00 $0.00
Disclosure

SEC source: 0001628280-20-009563 · wf-form4_159234455112778.xml · nonDerivative · entry 2

Kaul Samir · CIK 0001501915 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,059

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:55 UTC GrantSTOCK OPTION (RIGHT TO BUY) · Derivative 4,840 $0.00 Strike: $77.09 $0.00
Disclosure

SEC source: 0001628280-20-009562 · wf-form4_159234452903713.xml · derivative · entry 2

Jallal Bahija · CIK 0001730038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,840

Underlying: COMMON STOCK · 4,840 shares

Expires 2030-06-11

F1 · derivative.exercise_date: The stock option vests in full on the earlier to occur of (i) June 12, 2021 and (ii) the date of the next annual meeting of the Issuer's stockholders.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:55 UTC GrantCOMMON STOCK 2,757 $0.00 $0.00
Disclosure

SEC source: 0001628280-20-009562 · wf-form4_159234452903713.xml · nonDerivative · entry 1

Jallal Bahija · CIK 0001730038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,594

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:55 UTC
Gadde VijayaDirector
GrantSTOCK OPTION (RIGHT TO BUY) · Derivative 7,904 $0.00 Strike: $77.09 $0.00
Disclosure

SEC source: 0001628280-20-009561 · wf-form4_159234450610717.xml · derivative · entry 2

Gadde Vijaya · CIK 0001590851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,904

Underlying: COMMON STOCK · 7,904 shares

Expires 2030-06-11

F1 · derivative.exercise_date: The stock option vests as to 25% of the shares subject to such award on June 12, 2021, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of June 12, 2021, during the three-year period thereafter.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:55 UTC
Gadde VijayaDirector
GrantCOMMON STOCK 4,703 $0.00 $0.00
Disclosure

SEC source: 0001628280-20-009561 · wf-form4_159234450610717.xml · nonDerivative · entry 1

Gadde Vijaya · CIK 0001590851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,703

Read SEC document
June 10, 2020 Filed Jun 12, 2020 17:08 UTC Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative 6,000 $0.00 Strike: $5.94 $0.00
Disclosure

SEC source: 0001628280-20-009355 · wf-form4_159199611179204.xml · derivative · entry 3

MERESMAN STANLEY J · CIK 0001283102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,833

Underlying: COMMON STOCK · 6,000 shares

Expires 2028-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 17:08 UTC SaleCOMMON STOCK 6,000 $80.59 $483,540.00
Disclosure

SEC source: 0001628280-20-009355 · wf-form4_159199611179204.xml · nonDerivative · entry 2

MERESMAN STANLEY J · CIK 0001283102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,302

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 17:08 UTC Exercise / conversionCOMMON STOCK 6,000 $5.94 $35,640.00
Disclosure

SEC source: 0001628280-20-009355 · wf-form4_159199611179204.xml · nonDerivative · entry 1

MERESMAN STANLEY J · CIK 0001283102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,302

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2020 Filed Jun 8, 2020 20:23 UTC SaleCommon Stock 1,162,500 $83.16 $96,673,500.00
Disclosure

SEC source: 0001140361-20-013331 · form4.xml · nonDerivative · entry 2

SVF Bluebird (Cayman) Ltd · CIK 0001782391 · 10% owner

SOFTBANK VISION FUND (AIV M1) L.P. · CIK 0001755143 · 10% owner

SB INVESTMENT ADVISERS (UK) LTD · CIK 0001731509 · 10% owner

SVF Enterprise (Cayman) Ltd · CIK 0001782460 · 10% owner

SVF Endurance (Cayman) Ltd · CIK 0001782338 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,037,960

F1 · ownership.direct: SVF Bluebird (Cayman) Limited is a subsidiary of SVF Enterprise (Cayman) Limited and FPP (Cayman) Limited. SVF Enterprise (Cayman) Limited is a subsidiary of SVF Endurance (Cayman) Limited and FPP (Cayman) Limited. FPP (Cayman) Limited, pursuant to its holding shares in each entity, serves as a share trustee for each entity. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV MI) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager or AIFM of SoftBank Vision Fund (AIV MI) L.P., and is exclusively responsible for managing SoftBank Vision Fund (AIV MI) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. (continued to Fn. 2)

F2 · ownership.direct: (Continued from Fn.1) As AIFM of SoftBank Vision Fund (AIV MI) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV MI) L.P.'s Investments. Each Reporting Person disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission that any reporting person is the beneficial owner of such shares for purposes of the Securities Exchange Act of 1934 or for any other purpose.

Read SEC document
June 04, 2020 Filed Jun 8, 2020 20:23 UTC SaleCommon Stock 7,750,000 $83.16 $644,490,000.00
Disclosure

SEC source: 0001140361-20-013331 · form4.xml · nonDerivative · entry 1

SVF Bluebird (Cayman) Ltd · CIK 0001782391 · 10% owner

SOFTBANK VISION FUND (AIV M1) L.P. · CIK 0001755143 · 10% owner

SB INVESTMENT ADVISERS (UK) LTD · CIK 0001731509 · 10% owner

SVF Enterprise (Cayman) Ltd · CIK 0001782460 · 10% owner

SVF Endurance (Cayman) Ltd · CIK 0001782338 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,200,460

F1 · ownership.direct: SVF Bluebird (Cayman) Limited is a subsidiary of SVF Enterprise (Cayman) Limited and FPP (Cayman) Limited. SVF Enterprise (Cayman) Limited is a subsidiary of SVF Endurance (Cayman) Limited and FPP (Cayman) Limited. FPP (Cayman) Limited, pursuant to its holding shares in each entity, serves as a share trustee for each entity. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV MI) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager or AIFM of SoftBank Vision Fund (AIV MI) L.P., and is exclusively responsible for managing SoftBank Vision Fund (AIV MI) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. (continued to Fn. 2)

F2 · ownership.direct: (Continued from Fn.1) As AIFM of SoftBank Vision Fund (AIV MI) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV MI) L.P.'s Investments. Each Reporting Person disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission that any reporting person is the beneficial owner of such shares for purposes of the Securities Exchange Act of 1934 or for any other purpose.

Read SEC document
June 03, 2020 Filed Jun 4, 2020 20:46 UTC
Talasaz AmirAliDirector · Chairman, President and COO
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative 55,000 $0.00 Strike: $4.18 $0.00
Disclosure

SEC source: 0001628280-20-008989 · wf-form4_159130356922729.xml · derivative · entry 11

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 765,505

Underlying: COMMON STOCK · 55,000 shares

Expires 2022-07-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.

Read SEC document
June 03, 2020 Filed Jun 4, 2020 20:46 UTC
Talasaz AmirAliDirector · Chairman, President and COO
SaleCOMMON STOCK 900 $87.66 $78,890.04
Disclosure

SEC source: 0001628280-20-008989 · wf-form4_159130356922729.xml · nonDerivative · entry 8

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,689,532

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F7 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $87.55 to $87.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 03, 2020 Filed Jun 4, 2020 20:46 UTC
Talasaz AmirAliDirector · Chairman, President and COO
SaleCOMMON STOCK 5,007 $87.04 $435,816.79
Disclosure

SEC source: 0001628280-20-008989 · wf-form4_159130356922729.xml · nonDerivative · entry 7

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,690,432

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F6 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $86.54 to $87.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 03, 2020 Filed Jun 4, 2020 20:46 UTC
Talasaz AmirAliDirector · Chairman, President and COO
SaleCOMMON STOCK 22,455 $85.92 $1,929,320.13
Disclosure

SEC source: 0001628280-20-008989 · wf-form4_159130356922729.xml · nonDerivative · entry 6

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,695,439

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F5 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $85.54 to $86.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 03, 2020 Filed Jun 4, 2020 20:46 UTC
Talasaz AmirAliDirector · Chairman, President and COO
SaleCOMMON STOCK 26,638 $85.04 $2,265,375.43
Disclosure

SEC source: 0001628280-20-008989 · wf-form4_159130356922729.xml · nonDerivative · entry 5

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,717,894

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F4 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $84.53 to $85.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 03, 2020 Filed Jun 4, 2020 20:46 UTC
Talasaz AmirAliDirector · Chairman, President and COO
Exercise / conversionCOMMON STOCK 55,000 $4.18 $229,900.00
Disclosure

SEC source: 0001628280-20-008989 · wf-form4_159130356922729.xml · nonDerivative · entry 4

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,744,532

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 21:03 UTC
CLARK IAN TDirector
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative 2,690 $0.00 Strike: $4.18 $0.00
Disclosure

SEC source: 0001628280-20-009093 · wf-form4_159139101449845.xml · derivative · entry 3

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,830

Underlying: COMMON STOCK · 2,690 shares

Expires 2027-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on January 3, 2017.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 21:03 UTC
CLARK IAN TDirector
SaleCOMMON STOCK 2,690 $87.52 $235,428.80
Disclosure

SEC source: 0001628280-20-009093 · wf-form4_159139101449845.xml · nonDerivative · entry 2

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,302

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
June 03, 2020 Filed Jun 5, 2020 21:03 UTC
CLARK IAN TDirector
Exercise / conversionCOMMON STOCK 2,690 $4.18 $11,244.20
Disclosure

SEC source: 0001628280-20-009093 · wf-form4_159139101449845.xml · nonDerivative · entry 1

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,992

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 02, 2020 Filed Jun 4, 2020 20:46 UTC
Talasaz AmirAliDirector · Chairman, President and COO
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative 20,000 $0.00 Strike: $4.18 $0.00
Disclosure

SEC source: 0001628280-20-008989 · wf-form4_159130356922729.xml · derivative · entry 10

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 820,505

Underlying: COMMON STOCK · 20,000 shares

Expires 2022-07-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.

Read SEC document
June 02, 2020 Filed Jun 4, 2020 20:46 UTC
Talasaz AmirAliDirector · Chairman, President and COO
SaleCOMMON STOCK 10,000 $88.25 $882,500.00
Disclosure

SEC source: 0001628280-20-008989 · wf-form4_159130356922729.xml · nonDerivative · entry 3

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,689,532

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $88.00 to $88.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 02, 2020 Filed Jun 4, 2020 20:46 UTC
Talasaz AmirAliDirector · Chairman, President and COO
SaleCOMMON STOCK 10,000 $87.02 $870,173.00
Disclosure

SEC source: 0001628280-20-008989 · wf-form4_159130356922729.xml · nonDerivative · entry 2

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,699,532

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $87.00 to $87.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 02, 2020 Filed Jun 4, 2020 20:46 UTC
Talasaz AmirAliDirector · Chairman, President and COO
Exercise / conversionCOMMON STOCK 20,000 $4.18 $83,600.00
Disclosure

SEC source: 0001628280-20-008989 · wf-form4_159130356922729.xml · nonDerivative · entry 1

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,709,532

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 26, 2020 Filed May 26, 2020 21:16 UTC
CLARK IAN TDirector
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative 538 $0.00 Strike: $4.18 $0.00
Disclosure

SEC source: 0001628280-20-008423 · wf-form4_159052779266859.xml · derivative · entry 3

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,146

Underlying: COMMON STOCK · 538 shares

Expires 2027-11-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on October 25, 2017.

Read SEC document
May 26, 2020 Filed May 26, 2020 21:16 UTC
CLARK IAN TDirector
SaleCOMMON STOCK 538 $98.50 $52,993.00
Disclosure

SEC source: 0001628280-20-008423 · wf-form4_159052779266859.xml · nonDerivative · entry 2

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,302

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
May 26, 2020 Filed May 26, 2020 21:16 UTC
CLARK IAN TDirector
Exercise / conversionCOMMON STOCK 538 $4.18 $2,248.84
Disclosure

SEC source: 0001628280-20-008423 · wf-form4_159052779266859.xml · nonDerivative · entry 1

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,840

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 26, 2020 Filed May 28, 2020 00:50 UTC
Talasaz AmirAliDirector · Chairman, President and COO
GrantPerformance-Based Restricted Stock Units · Derivative 1,695,574 $0.00 $0.00
Disclosure

SEC source: 0001628280-20-008488 · wf-form4_159062700627333.xml · derivative · entry 1

Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,695,574

Underlying: COMMON STOCK · 1,695,574 shares

Expires 2027-05-26

F1 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The performance-based restricted stock units vest, if at all, based on the Issuer's achievement of certain stock price milestones.

Read SEC document
May 26, 2020 Filed May 28, 2020 00:50 UTC
Eltoukhy HelmyDirector · Chief Executive Officer
GrantPerformance-Based Restricted Stock Units · Derivative 1,695,574 $0.00 $0.00
Disclosure

SEC source: 0001628280-20-008487 · wf-form4_159062698434178.xml · derivative · entry 1

Eltoukhy Helmy · CIK 0001752968 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,695,574

Underlying: COMMON STOCK · 1,695,574 shares

Expires 2027-05-26

F1 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The performance-based restricted stock units vest, if at all, based on the Issuer's achievement of certain stock price milestones.

Read SEC document
May 22, 2020 Filed May 26, 2020 17:17 UTC
BERTOCCI DEREK AChief Financial Officer
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative 1,537 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001628280-20-008424 · wf-form4_159052781513744.xml · derivative · entry 7

BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,751

Underlying: COMMON STOCK · 1,537 shares

Expires 2028-08-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018.

Read SEC document
May 22, 2020 Filed May 26, 2020 17:17 UTC
BERTOCCI DEREK AChief Financial Officer
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative 7,685 $0.00 Strike: $3.63 $0.00
Disclosure

SEC source: 0001628280-20-008424 · wf-form4_159052781513744.xml · derivative · entry 6

BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,686

Underlying: COMMON STOCK · 7,685 shares

Expires 2026-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the options on July 18, 2017, thereafter vests in equal monthly installments over 36 months.

Read SEC document
May 22, 2020 Filed May 26, 2020 17:17 UTC
BERTOCCI DEREK AChief Financial Officer
SaleCOMMON STOCK 1,144 $97.00 $110,972.00
Disclosure

SEC source: 0001628280-20-008424 · wf-form4_159052781513744.xml · nonDerivative · entry 5

BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,187

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F4 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $96.97 to $97.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 22, 2020 Filed May 26, 2020 17:17 UTC
BERTOCCI DEREK AChief Financial Officer
SaleCOMMON STOCK 6,960 $96.77 $673,542.17
Disclosure

SEC source: 0001628280-20-008424 · wf-form4_159052781513744.xml · nonDerivative · entry 4

BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,331

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $95.97 to $96.955, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 22, 2020 Filed May 26, 2020 17:17 UTC
BERTOCCI DEREK AChief Financial Officer
SaleCOMMON STOCK 1,118 $95.38 $106,631.60
Disclosure

SEC source: 0001628280-20-008424 · wf-form4_159052781513744.xml · nonDerivative · entry 3

BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,291

F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $94.87 to $95.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 22, 2020 Filed May 26, 2020 17:17 UTC
BERTOCCI DEREK AChief Financial Officer
Exercise / conversionCOMMON STOCK 1,537 $8.80 $13,525.60
Disclosure

SEC source: 0001628280-20-008424 · wf-form4_159052781513744.xml · nonDerivative · entry 2

BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,409

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 22, 2020 Filed May 26, 2020 17:17 UTC
BERTOCCI DEREK AChief Financial Officer
Exercise / conversionCOMMON STOCK 7,685 $3.63 $27,896.55
Disclosure

SEC source: 0001628280-20-008424 · wf-form4_159052781513744.xml · nonDerivative · entry 1

BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,872

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2020 Filed Jun 16, 2020 17:56 UTC
Kaul SamirDirector
GiftCOMMON STOCK 6,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-20-009563 · wf-form4_159234455112778.xml · nonDerivative · entry 1

Kaul Samir · CIK 0001501915 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 81,943

F1 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.